Amid rapid technological advancements and regulatory uncertainty, navigating the life sciences ecosystem can be challenging.

What do life sciences companies need to know about capital markets heading into 2026?

The femtech sector's evolution presents opportunities for tech, healthcare, and life sciences companies that are both vast and largely...

In an unusual move, the U.S. Department of Justice and U.S. Patent and Trademark Office submitted a “Statement of Interest” this week in...

A break fee in a merger-gone-south can be deducted as an ordinary expense, the U.S. Tax Court held today, finding for biopharmaceutical...

As BIO 2025 approaches in Boston, eight pivotal trends are emerging at the intersection of science, business, IP, and regulation:...

I recently had the chance to contribute to a thoughtful and timely piece by my good friend and podcast co-host, Halle Tecco. After 15...

The Centers for Medicare & Medicaid Services (CMS) has issued a new Request for Information (RFI) aimed at transforming how digital...

Last year saw growing investment in digital health startups addressing women+ health needs—but women still lag behind men when it comes...

In Actavis v. U.S., a case at the intersection of tax law and patent law, the Federal Circuit held that generic drug companies’...

In an attempt to facilitate capital raising, the SEC announced that it was expanding the ability of issuers to submit draft registration...